Literature DB >> 31258

Metabolism of drugs and carcinogens in man: antipyrine elimination as an indicator.

R Kalamegham, K Krishnaswamy, S Krishnamurthy, R N Bhargava.   

Abstract

The suitability of the most commonly used "prototype" drug, viz, antipyrine, in predicting drug and carcinogen metabolism was evaluated, by studying in vivo antipyrine elimination rate (Ke) and in vitro metabolism of drugs and carcinogens in liver preparations in the same individuals. Our subjects were 20 adult males undergoing abdominal surgery for gastrojejunostomy, although antipyrine Ke could be studied in only 16 subjects. Correlations of the various in vito--in vivo parameters were positive between the parameter pairs: in vivo antipyrine Ke--in vitro benzopyrene hydroxylase; benzopyrene hydroxylase--aniline hydroxylase; and benzopyrene hydroxylase--gamma-glutamyl transferase. Aminopyrine demethylase did not correlate with any of the parameters studied. The degree of correlation between antipyrine Ke and benzopyrene hydroxylase was statistically significant but was not satisfactory for predictive purposes. Our study indicates some of the problems and limitations of in vivo--in vitro comparisons and confirms earlier doubts on the usefulness of antipyrine as a "prototype" drug for predicting drug and carcinogen metabolism in man.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 31258     DOI: 10.1002/cpt197925167

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  6 in total

1.  Histamine release by free radicals: paracetamol-induced histamine release from rat peritoneal mast cells after in vitro activation by monooxygenase.

Authors:  E Masini; M Lodovici; R Fantozzi; S Brunelleschi; A Conti; P F Mannaioni
Journal:  Agents Actions       Date:  1986-04

2.  Antipyrine clearance and metabolism in patients with psoriasis.

Authors:  K Kubota; T Ishizaki; K Chiba; A Takagi; A Nakagawa; K Nakamura
Journal:  Br J Clin Pharmacol       Date:  1986-10       Impact factor: 4.335

Review 3.  Genetic predisposition to lung cancer.

Authors:  M R Law
Journal:  Br J Cancer       Date:  1990-02       Impact factor: 7.640

4.  Coumarin 7-hydroxylase activity in human liver microsomes. Properties of the enzyme and interspecies comparisons.

Authors:  O Pelkonen; E A Sotaniemi; J T Ahokas
Journal:  Br J Clin Pharmacol       Date:  1985-01       Impact factor: 4.335

5.  Salivary antipyrine half-life during injectable progestagen contraception.

Authors:  J V Joshi; K C Gupta; K T Hazari; J Gokral; S Pohujani; R Satoskar
Journal:  Clin Pharmacokinet       Date:  1986 Mar-Apr       Impact factor: 6.447

6.  Influence of liver disease and environmental factors on hepatic monooxygenase activity in vitro.

Authors:  M J Brodie; A R Boobis; C J Bulpitt; D S Davies
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.